Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026 and Aug 2026.
- Largest single sale: $383K (6,368 shares) of Xenon Pharmaceuticals Inc. on Aug 28, 2026. Filing
- Last sale before this period: Mar 24, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Xenon Pharmaceuticals Inc. (XENE) | Chief Medical Officer | Aug 25, 2021 | Aug 31, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 28, 2026, Xenon Pharmaceuticals Inc.: sold 7,068 shares for $426K, under a disclosed plan. 1 filing: 1
- Mar 13, 2026, Xenon Pharmaceuticals Inc.: sold 1,410 shares for $78K, under a disclosed plan. 1 filing: 1
- Mar 12, 2026, Xenon Pharmaceuticals Inc.: 3,750 shares vested. 1 filing: 1
- Mar 10, 2026, Xenon Pharmaceuticals Inc.: sold 2,771 shares for $167K, under a disclosed plan. 1 filing: 1
- Mar 9, 2026, Xenon Pharmaceuticals Inc.: 7,500 shares vested. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.